Skip to content

The effect of vitamin D3 supplementation on AKI risk in multiple trauma patients admitted to ICU with elevated CPK level

The effect of vitamin D3 supplementation on AKI risk in multiple trauma patients admitted to ICU with elevated CPK level

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20120703010178N23
Enrollment
30
Registered
2021-01-16
Start date
2020-01-21
Completion date
Unknown
Last updated
2021-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute kidney injury (AKI) refers to an abrupt decrease in kidney function, resulting in the retention of urea and other nitrogenous waste products and in the dysregulation of extracellular volume and electrolytes. Acute kidney injury

Interventions

Intervention 1: Control group : patients with serum CPK level higher than 1000 I.U, no intervention, just observational. Intervention 2: Intervention group: : patients with serum CPK level>1000 I.U,

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: patients over 18 patients with at least two distinct injuries who were diagnosed with multiple trauma Serum creatinine phosphate level higher than or equal to 5 times normal, from admission to the intensive care unit up to 48 hours later

Exclusion criteria

Exclusion criteria: Patients with a recent history of myocardial infarction (within one week before the trauma) pregnancy or lactation, patients with direct kidney trauma high serum vitamin D3 levels patients who received more than 2000I.U of vitamin D3 per day during the past week, total calcium level above 9 mg/dl or phosphate level above 6 mg/dl at the time of admission, history of organ transplantation or long-term use of immunosuppressive drugs, patients with a history of diseases related to vitamin D3 levels, such as primary parathyroid, metabolic bone disease, or acute renal failure

Design outcomes

Primary

MeasureTime frame
Prevalence of acute kidney injurie. Timepoint: within 2 weeks if ICU admission. Method of measurement: laboratory results of Serum creatinine; urine output.;Serum creatine phosphokinase level. Timepoint: Daily from the ICU admission date up to either reaching normal level or 14 days. Method of measurement: Serum CPK level laboratory measurement kits.

Secondary

MeasureTime frame
Follow up death for 28 days. Timepoint: since admitted it the ICU we follow up daily up to 28 days. Method of measurement: dead or alive before the 28 days follow up.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Sistanizad

Shahid Beheshti University of Medical Sciences

sistanizadm@sbmu.ac.ir+98 21 8820 0087

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026